Skip to main content
Erschienen in: BMC Gastroenterology 1/2010

Open Access 01.12.2010 | Case report

Drain tube migration into the anastomotic site of an esophagojejunostomy for gastric small cell carcinoma: short report

verfasst von: Peng-Sheng Lai, Chiao Lo, Long-Wei Lin, Po-Chu Lee

Erschienen in: BMC Gastroenterology | Ausgabe 1/2010

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Intraluminal migration of a drain through an anastomotic site is a rare complication of gastric surgery.

Case Presentation

We herein report the intraluminal migration of a drain placed after a lower esophagectomy and total gastrectomy with Roux-en-Y anastomosis for gastric small cell carcinoma. Persistent drainage was noted 1 month after surgery, and radiographic studies were consistent with drain tube migration. Endoscopy revealed the drain had migrated into the esophagojejunostomy anastomotic site. The drain was removed from outside of abdominal wound while observing the anastomotic site endoscopically. The patient was treated with suction via a nasogastric tube drain for 5 days, and thereafter had an uneventful recovery.

Conclusions

Though drain tube migration is a rare occurrence, it should be considered in patients with persistent drainage who have undergone gastric surgery.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-230X-10-50) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

PSL and PCL participated in the surgery. CL helped to draft the manuscript. LWL performed the pathologic examination. All authors read and approved the final manuscript.

Background

Intraluminal migration of a drain through an anastomotic site is a rare complication of gastric surgery [1]. The condition frequently presents with persistent drainage, and diagnosis is made by radiographic studies. We herein report the intraluminal migration of a drain placed after a lower esophagectomy and total gastrectomy with Roux-en-Y anastomosis for gastric small cell carcinoma. The drain was removed via the abdominal wound while the anastomosis was visualized endoscopically.

Case Presentation

A 67-year-old man presented with a 6-week history of hiccupping and foul odor. He also complained of difficulty swallowing, diffuse epigastric pain, and weight loss. Panendoscopy revealed a large ulcerated mass at least 8 cm in diameter at the lesser curvature side of the anterior wall of the gastric upper body, with invasion into the lower esophagus. Biopsy was consistent with small cell carcinoma. Chest, abdominal and pelvic computed tomography (CT) showed distal esophageal involvement and lymphadenopathy, but no evidence of liver or distal metastasis. A lower esophagectomy, total gastrectomy with Roux-en-Y anastomosis, and feeding jejunostomy were performed. A 13-mm vacuum drain tube was inserted intraoperatively adjacent to the anastomotic site.
Postoperatively, approximately 80 ml of yellowish-white, foamy, foul smelling fluid was collecting from the drain tube each day. This drainage persisted for 1 month after surgery. CT was performed, and the result was consistent with drain tube migration (Figure 1). Panendoscopy indicated the drain had migrated into the esophagojejunostomy anastomotic site (Figure 2). The drain was removed from the outside of abdominal drain wound while observing the anastomotic site endoscopically. After the drain was removed, no intraperitoneal organs (such as small bowel, liver, or spleen) were visible. The mucosal defect over the anastomotic site caused by the migrated drain appeared to be well approximated after removal of the drain. The patient was treated with suction via a nasogastric tube drain for 5 days. He thereafter had an uneventful recovery.
The patient subsequently was treated with 4 cycles of combination chemotherapy consisting of cisplatin and etoposide (VP-16). Sixteen months after surgery the patient was alive and showed no signs of cancer recurrence. The patient discussed in this report provided informed consent for all treatments rendered and consent for the publication of this case report and the use of radiological images.

Discussion

Anastomotic leakage after gastric surgery is a relatively common complication occurring in 10% to 15% of patients and carries a mortality of approximately 5% [2, 3]. Management of leakage may be operative or non-operative, and most surgeons routinely place prophylactic drains at the anastomotic site during the initial surgery [4]. Persistent drainage is frequently the first sign of anastomotic leakage or drain migration [1]. The migration of a drain tube into the anastomotic site of an esophagojejunostomy is a rare complication after a gastrectomy [1].
Diagnosis of anastomotic leakage or drain migration is made based on contrast radiographic studies, i.e., evidence of leakage after radio-contrast examination may indicate anastomotic leakage or drain migration, as was present in our case [1]. It is uncertain how intraluminal migration of a drain may occur, though authors believe it may be a result of migration through the site of an anastomotic leak. In most cases, the drain is repositioned, either surgically or under radiographic guidance, and left in place as the anastomosis heals.
In the case presented herein, we left the drain in place because the color, amount, and odor of the drainage made us suspect there was minor leakage of the esophagojejunostomy anastomotic site. Because the amount of drainage did not decrease over the course of a month, we were concerned about the integrity of the anastomosis, and thus decided to check the esophagojejunostomy anastomotic site endoscopically. In this case, visualization of the anastomotic site endoscopically allowed us to confirm the integrity of the anastomosis after the drain was removed and determine that surgical correction was not required.

Conclusion

In conclusion, intraluminal drain migration is a rare complication after gastric surgery, however, should be considered in cases where there is persistent drainage. Diagnosis is made by radiographic studies, and endoscopy offers an additional diagnostic modality.
Written consent for publication was obtained from the patient.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

PSL and PCL participated in the surgery. CL helped to draft the manuscript. LWL performed the pathologic examination. All authors read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
1.
Zurück zum Zitat Wilmot AS, Levine MS, Rubesin SE, Kucharczuk JC, Laufer I: Intraluminal migration of surgical drains after transhiatal esophagogastrectomy: radiographic findings and clinical relevance. AJR Am J Roentgenol. 2007, 189: 780-785. 10.2214/AJR.07.2322.CrossRefPubMed Wilmot AS, Levine MS, Rubesin SE, Kucharczuk JC, Laufer I: Intraluminal migration of surgical drains after transhiatal esophagogastrectomy: radiographic findings and clinical relevance. AJR Am J Roentgenol. 2007, 189: 780-785. 10.2214/AJR.07.2322.CrossRefPubMed
2.
Zurück zum Zitat Orringer MB, Marshall B, Iannettoni MD: Transhiatal esophagectomy for treatment of benign and malignant esophageal disease. World J Surg. 2001, 25: 196-203. 10.1007/s002680020019.CrossRefPubMed Orringer MB, Marshall B, Iannettoni MD: Transhiatal esophagectomy for treatment of benign and malignant esophageal disease. World J Surg. 2001, 25: 196-203. 10.1007/s002680020019.CrossRefPubMed
3.
Zurück zum Zitat Atkins BZ, Shah AS, Hutcheson KA, Mangum JH, Pappas TN, Harpole DH, D'Amico TA: Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004, 78: 1170-1176. 10.1016/j.athoracsur.2004.02.034.CrossRefPubMed Atkins BZ, Shah AS, Hutcheson KA, Mangum JH, Pappas TN, Harpole DH, D'Amico TA: Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004, 78: 1170-1176. 10.1016/j.athoracsur.2004.02.034.CrossRefPubMed
4.
Zurück zum Zitat Thodiyil PA, Yenumula P, Rogula T, Gorecki P, Fahoum B, Gourash W, Ramanathan R, Mattar SG, Shinde D, Arena VC, Wise L, Schauer P: Selective nonoperative management of leaks after gastric bypass: lessons learned from 2675 consecutive patients. Ann Surg. 2008, 248: 782-792. 10.1097/SLA.0b013e31818584aa.CrossRefPubMed Thodiyil PA, Yenumula P, Rogula T, Gorecki P, Fahoum B, Gourash W, Ramanathan R, Mattar SG, Shinde D, Arena VC, Wise L, Schauer P: Selective nonoperative management of leaks after gastric bypass: lessons learned from 2675 consecutive patients. Ann Surg. 2008, 248: 782-792. 10.1097/SLA.0b013e31818584aa.CrossRefPubMed
Metadaten
Titel
Drain tube migration into the anastomotic site of an esophagojejunostomy for gastric small cell carcinoma: short report
verfasst von
Peng-Sheng Lai
Chiao Lo
Long-Wei Lin
Po-Chu Lee
Publikationsdatum
01.12.2010
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2010
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-10-50

Weitere Artikel der Ausgabe 1/2010

BMC Gastroenterology 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.